{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:19:19Z","timestamp":1762607959001,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000049","name":"Ontario Neurotrauma Foundation","doi-asserted-by":"publisher","award":["2081-RHI-CATNP-1058","2081-RHI-CATNP-1058"],"award-info":[{"award-number":["2081-RHI-CATNP-1058","2081-RHI-CATNP-1058"]}],"id":[{"id":"10.13039\/501100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41393-020-0508-5","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T12:38:28Z","timestamp":1593607108000},"page":"112-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cannabinoids and an anti-inflammatory diet for the treatment of neuropathic pain after spinal cord injury (The CATNP Study): study protocol for a randomized controlled trial"],"prefix":"10.1038","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-4265","authenticated-orcid":false,"given":"David J.","family":"Allison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandria Roa","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5037-0446","authenticated-orcid":false,"given":"Brian C. F.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Ditor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldon","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"508_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.sc.3101116.","volume":"39","author":"PJ Siddall","year":"2001","unstructured":"Siddall PJ, Loeser JD. Pain following spinal cord injury. Spinal Cord. 2001;39:63\u201373. https:\/\/doi.org\/10.1038\/sj.sc.3101116.","journal-title":"Spinal Cord"},{"key":"508_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1155\/2004\/863062.","volume":"9","author":"P Henwood","year":"2004","unstructured":"Henwood P, Ellis JA. Chronic neuropathic pain in spinal cord injury: the patient\u2019s perspective. Pain Res Manag. 2004;9:39\u201345. https:\/\/doi.org\/10.1155\/2004\/863062.","journal-title":"Pain Res Manag"},{"key":"508_CR3","first-page":"65","volume":"9","author":"JC Ashton","year":"2008","unstructured":"Ashton JC, Milligan ED. Cannabinoids for the treatment of neuropathic pain: clinical evidence. Curr Opin Investig Drugs. 2008;9:65\u201375.","journal-title":"Curr Opin Investig Drugs"},{"key":"508_CR4","doi-asserted-by":"crossref","unstructured":"Cardenas DD, Jensen MP. Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study 2005:109\u201317.","DOI":"10.1080\/10790268.2006.11753864"},{"key":"508_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2147\/JPR.S134330.","volume":"10","author":"JM Corroon","year":"2017","unstructured":"Corroon JM, Mischley LK, Sexton M. Cannabis as a substitute for prescription drugs\u2014a cross-sectional study. J Pain Res. 2017;10:989\u201398. https:\/\/doi.org\/10.2147\/JPR.S134330.","journal-title":"J Pain Res"},{"key":"508_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1089\/acm.2017.0184.","volume":"24","author":"D Bruce","year":"2018","unstructured":"Bruce D, Brady JP, Foster E, Shattell M. Preferences for medical marijuana over prescription medications among persons living with chronic conditions: alternative, complementary, and tapering uses. J Alter Complement Med. 2018;24:146\u201353. https:\/\/doi.org\/10.1089\/acm.2017.0184.","journal-title":"J Alter Complement Med"},{"key":"508_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/can.2017.0012.","volume":"2","author":"A Reiman","year":"2017","unstructured":"Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017;2:160\u20136. https:\/\/doi.org\/10.1089\/can.2017.0012.","journal-title":"Cannabis Cannabinoid Res"},{"key":"508_CR8","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1038\/525S15a.","volume":"525","author":"M Eisenstein","year":"2015","unstructured":"Eisenstein M. Medical marijuana: showdown at the cannabis corral. Nature. 2015;525:S15\u20137. https:\/\/doi.org\/10.1038\/525S15a.","journal-title":"Nature"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b.","volume":"65","author":"DJ Rog","year":"2005","unstructured":"Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65:812\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000176753.45410.8b.","journal-title":"Neurology"},{"key":"508_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0814-x.","volume":"18","author":"S Nielsen","year":"2018","unstructured":"Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep. 2018;18:8. https:\/\/doi.org\/10.1007\/s11910-018-0814-x.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"508_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-014-0451-2.","volume":"18","author":"PG Fine","year":"2014","unstructured":"Fine PG, Rosenfeld MJ. Cannabinoids for neuropathic pain. Curr Pain Headache Rep. 2014;18:451. https:\/\/doi.org\/10.1007\/s11916-014-0451-2.","journal-title":"Curr Pain Headache Rep"},{"key":"508_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1038\/sc.2016.90.","volume":"54","author":"SD Guy","year":"2016","unstructured":"Guy SD, Mehta S, Casalino A, C\u00f4t\u00e9 I, Kras-Dupuis A, Moulin DE, et al. The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord: recommendations for treatment. Spinal Cord. 2016;54:S14\u201323. https:\/\/doi.org\/10.1038\/sc.2016.90.","journal-title":"Spinal Cord"},{"key":"508_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0625-4.","volume":"13","author":"DJ Allison","year":"2016","unstructured":"Allison DJ, Thomas A, Beaudry K, Ditor DS. Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial. J Neuroinflammation. 2016;13:152. https:\/\/doi.org\/10.1186\/s12974-016-0625-4.","journal-title":"J Neuroinflammation"},{"key":"508_CR14","doi-asserted-by":"publisher","unstructured":"Vu\u010dkovic S, Srebro D, Vujovic KS, Vu\u010detic \u010c, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9. https:\/\/doi.org\/10.3389\/fphar.2018.01259.","DOI":"10.3389\/fphar.2018.01259"},{"key":"508_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S1471-4914(02)02383-3.","volume":"8","author":"TA Samad","year":"2002","unstructured":"Samad TA, Sapirstein A, Woolf CJ. Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med. 2002;8:390\u20136. https:\/\/doi.org\/10.1016\/S1471-4914(02)02383-3.","journal-title":"Trends Mol Med"},{"key":"508_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1530-7085.2003.03034.x.","volume":"3","author":"CT Hartrick","year":"2003","unstructured":"Hartrick CT, Kovan JP, Shapiro S. The numeric rating scale for clinical pain measurement: a ratio measure? Pain Pract. 2003;3:310\u20136. https:\/\/doi.org\/10.1111\/j.1530-7085.2003.03034.x.","journal-title":"Pain Pract"},{"key":"508_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00002508-200309000-00004","volume":"19","author":"SJ Krause","year":"2003","unstructured":"Krause SJ, Backonja M-M. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19:306\u201314.","journal-title":"Clin J Pain"},{"key":"508_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sc.2014.4.","volume":"52","author":"E Widerstr\u00f6m-Noga","year":"2014","unstructured":"Widerstr\u00f6m-Noga E, Biering-S\u00f8rensen F, Bryce TN, Cardenas DD, Finnerup NB, Jensen MP, et al. The international spinal cord injury pain basic data set (version 2.0). Spinal Cord. 2014;52:282\u20136. https:\/\/doi.org\/10.1038\/sc.2014.4.","journal-title":"Spinal Cord"},{"key":"508_CR19","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jpain.2009.01.258.","volume":"10","author":"L Ferguson","year":"2009","unstructured":"Ferguson L, Scheman J. Patient global impression of change scores within the context of a chronic pain rehabilitation program. J Pain. 2009;10:S73. https:\/\/doi.org\/10.1016\/j.jpain.2009.01.258.","journal-title":"J Pain"},{"key":"508_CR20","unstructured":"McCaffery M, Beebe A. Pain: Clinical Manual for Nursing Practice. Mosby, St. Louis. 1989."},{"key":"508_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7748\/ns.9.11.55.s69.","volume":"9","author":"M McCaffery","year":"1994","unstructured":"McCaffery M, Beebe A. Pain: clinical manual for nursing practicePain: clinical manual for nursing practice. Nurs Stand. 1994;9:55. https:\/\/doi.org\/10.7748\/ns.9.11.55.s69.","journal-title":"Nurs Stand"},{"key":"508_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.sc.3102127.","volume":"46","author":"WC Miller","year":"2008","unstructured":"Miller WC, Anton HA, Townson AF. Measurement properties of the CESD scale among individuals with spinal cord injury. Spinal Cord. 2008;46:287\u201392. https:\/\/doi.org\/10.1038\/sj.sc.3102127.","journal-title":"Spinal Cord"},{"key":"508_CR23","first-page":"Doc06","volume":"4","author":"M Morfeld","year":"2007","unstructured":"Morfeld M, Petersen C, Kr\u00fcger-B\u00f6deker A, von Mackensen S, Bullinger M. The assessment of mood at workplace\u2014psychometric analyses of the revised Profile of Mood States (POMS) questionnaire. Psychosoc Med. 2007;4:Doc06.","journal-title":"Psychosoc Med"},{"key":"508_CR24","doi-asserted-by":"publisher","unstructured":"Shahid A, Wilkinson K, Marcu S, Shapiro CM. Leeds Sleep Evaluation Questionnaire (LSEQ). In: STOP, THAT one hundred other sleep scales. New York: Springer; 2011. pp. 211\u20133. https:\/\/doi.org\/10.1007\/978-1-4419-9893-4_48.","DOI":"10.1007\/978-1-4419-9893-4_48"},{"key":"508_CR25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.apmr.2007.06.012.","volume":"88","author":"MM Adams","year":"2007","unstructured":"Adams MM, Ginis KAM, Hicks AL. The spinal cord injury spasticity evaluation tool: development and evaluation. Arch Phys Med Rehabil. 2007;88:1185\u201392. https:\/\/doi.org\/10.1016\/j.apmr.2007.06.012.","journal-title":"Arch Phys Med Rehabil"},{"key":"508_CR26","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res"},{"key":"508_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s11136-014-0873-7","volume":"24","author":"D Golicki","year":"2015","unstructured":"Golicki D, Niewada M, Karli\u0144ska A, Buczek J, Kobayashi A, Janssen MF, et al. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Qual Life Res. 2015;24:1555\u201363. https:\/\/doi.org\/10.1007\/s11136-014-0873-7.","journal-title":"Qual Life Res"},{"key":"508_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jval.2015.05.009.","volume":"18","author":"C Bouwmans","year":"2015","unstructured":"Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Roijen Van LH. The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Heal. 2015;18:753\u20138. https:\/\/doi.org\/10.1016\/j.jval.2015.05.009.","journal-title":"Value Heal"},{"key":"508_CR29","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff.","volume":"67","author":"PJ Siddall","year":"2006","unstructured":"Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology. 2006;67:1792\u2013800. https:\/\/doi.org\/10.1212\/01.wnl.0000244422.45278.ff.","journal-title":"Neurology"},{"key":"508_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x.","volume":"18","author":"M Serpell","year":"2014","unstructured":"Serpell M, Ratcliffe S, Hovorka J, Schofield M, Taylor L, Lauder H, et al. A double-blind, randomized, placebo-controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment. Eur J Pain. 2014;18:999\u20131012. https:\/\/doi.org\/10.1002\/j.1532-2149.2013.00445.x.","journal-title":"Eur J Pain"},{"key":"508_CR31","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0.","volume":"353","author":"CJ Woolf","year":"1999","unstructured":"Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(99)01307-0.","journal-title":"Lancet"},{"key":"508_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/s0304-3940(03)01387-9.","volume":"361","author":"C Sommer","year":"2004","unstructured":"Sommer C. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361:184\u20137. https:\/\/doi.org\/10.1016\/s0304-3940(03)01387-9.","journal-title":"Neurosci Lett"},{"key":"508_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3940(91)90444-X.","volume":"132","author":"S Pitchford","year":"1991","unstructured":"Pitchford S, Levine JD. Prostaglandins sensitize nociceptors in cell culture. Neurosci Lett. 1991;132:105\u20138. https:\/\/doi.org\/10.1016\/0304-3940(91)90444-X.","journal-title":"Neurosci Lett"},{"key":"508_CR34","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.apmr.2007.08.004.","volume":"88","author":"AL Davies","year":"2007","unstructured":"Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil. 2007;88:1384\u201393. https:\/\/doi.org\/10.1016\/j.apmr.2007.08.004.","journal-title":"Arch Phys Med Rehabil"},{"key":"508_CR35","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/08977150260139129.","volume":"19","author":"KC Hayes","year":"2002","unstructured":"Hayes KC, Hull TCL, Delaney GA, Potter PJ, Sequeira KAJ, Campbell K, et al. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma. 2002;19:753\u201361. https:\/\/doi.org\/10.1089\/08977150260139129.","journal-title":"J Neurotrauma"},{"key":"508_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/nu2030355.","volume":"2","author":"PC Calder","year":"2010","unstructured":"Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2:355\u201374. https:\/\/doi.org\/10.3390\/nu2030355.","journal-title":"Nutrients"},{"key":"508_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/npp.2017.222.","volume":"43","author":"MA Ware","year":"2018","unstructured":"Ware MA. Medical cannabis research: issues and priorities. Neuropsychopharmacology. 2018;43:214\u20135. https:\/\/doi.org\/10.1038\/npp.2017.222.","journal-title":"Neuropsychopharmacology"},{"key":"508_CR38","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1213\/ANE.0000000000002110.","volume":"125","author":"H Meng","year":"2017","unstructured":"Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A. Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis. Anesth Analg. 2017;125:1638\u201352. https:\/\/doi.org\/10.1213\/ANE.0000000000002110.","journal-title":"Anesth Analg"},{"key":"508_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023.","volume":"166","author":"JL Croxford","year":"2005","unstructured":"Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J Neuroimmunol. 2005;166:3\u201318. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.04.023.","journal-title":"J Neuroimmunol"},{"key":"508_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254.","volume":"46","author":"K Mackie","year":"2006","unstructured":"Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharm Toxicol. 2006;46:101\u201322. https:\/\/doi.org\/10.1146\/annurev.pharmtox.46.120604.141254.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"508_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/clpt.2010.318.","volume":"89","author":"EL Karschner","year":"2011","unstructured":"Karschner EL, Darwin WD, McMahon RP, Liu F, Wright S, Goodwin RS, et al. Subjective and physiological effects after controlled sativex and oral THC administration. Clin Pharm Ther. 2011;89:400\u20137. https:\/\/doi.org\/10.1038\/clpt.2010.318.","journal-title":"Clin Pharm Ther"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0508-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41393-020-0508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:39:50Z","timestamp":1684618790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-020-0508-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1038\/s41393-020-0508-5","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"type":"print","value":"1362-4393"},{"type":"electronic","value":"1476-5624"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol, informed consent form, recruitment materials, and all participant materials will be submitted for ethical approval through the University of Western REB and the Brock University REB prior to participant recruitment. The study will be conducted in full conformity with the ICH E6, Health Canada Food and Drugs Act, and Good Clinical Practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}